UK markets closed
NIKKEI 225
28,162.83 -120.20 (-0.42%) HANG SENG
17,297.94 -275.64 (-1.57%) CRUDE OIL
76.66 +0.38 (+0.50%) GOLD FUTURES
1,739.80 -14.20 (-0.81%) DOW
33,849.46 -497.57 (-1.45%) BTC-GBP
13,581.16 -351.43 (-2.52%)
Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 4.07B |
| Enterprise value | 3.03B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 33.26 |
| Price/book (mrq) | 5.02 |
| Enterprise value/revenue | 27.34 |
| Enterprise value/EBITDA | -9.95 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.45 |
| 52-week change 3 | -32.42% |
| S&P500 52-week change 3 | -13.51% |
| 52-week high 3 | 48.46 |
| 52-week low 3 | 20.24 |
| 50-day moving average 3 | 29.76 |
| 200-day moving average 3 | 30.10 |
Share statistics
| Avg vol (3-month) 3 | 822.12k |
| Avg vol (10-day) 3 | 554k |
| Shares outstanding 5 | 135.81M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 108.49M |
| % held by insiders 1 | 14.79% |
| % held by institutions 1 | 69.38% |
| Shares short (14 Nov 2022) 4 | 6.92M |
| Short ratio (14 Nov 2022) 4 | 6.65 |
| Short % of float (14 Nov 2022) 4 | 7.25% |
| Short % of shares outstanding (14 Nov 2022) 4 | 5.10% |
| Shares short (prior month 13 Oct 2022) 4 | 7.29M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | -273.34% |
| Operating margin (ttm) | -282.33% |
Management effectiveness
| Return on assets (ttm) | -14.59% |
| Return on equity (ttm) | -33.19% |
Income statement
| Revenue (ttm) | 110.69M |
| Revenue per share (ttm) | 0.90 |
| Quarterly revenue growth (yoy) | -32.70% |
| Gross profit (ttm) | -216.69M |
| EBITDA | -304.14M |
| Net income avi to common (ttm) | -302.57M |
| Diluted EPS (ttm) | -2.34 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.11B |
| Total cash per share (mrq) | 8.14 |
| Total debt (mrq) | 62.05M |
| Total debt/equity (mrq) | 7.65 |
| Current ratio (mrq) | 3.16 |
| Book value per share (mrq) | 6.55 |
Cash flow statement
| Operating cash flow (ttm) | -237.55M |
| Levered free cash flow (ttm) | 182.18M |
© 2022 Yahoo. All rights reserved.
